- Research Tracker
- Supplement safety
- Turmeric and curcumin
What public sources say about the safety of turmeric and curcumin: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.
Interactions and safety, in NIH's words
Conventionally formulated oral turmeric or curcumin (not modified to enhance bioavailability) is likely safe in the recommended amounts for up to 2 or 3 months.
Oral turmeric can cause adverse effects such as nausea and vomiting, acid reflux, stomach upset, diarrhea, or constipation. Topical curcumin can cause hives or itching.
Many curcumin products with increased bioavailability are on the market, and liver damage has been reported in some people who have consumed these bioavailable formulations. If you notice any liver damage symptoms such as fatigue, nausea, poor appetite, dark urine, or jaundice, stop consuming turmeric or curcumin products immediately and talk with your health care provider.
Quoted from the “What Do We Know About Safety?” section: NIH National Center for Complementary and Integrative Health, retrieved 2026-11-16. Read the full page for the complete list and references.
FDA adverse-event reports (CAERS)
Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “TURMERIC”, “CURCUMIN”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.
Combination products: 81 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 247 reports where a product is named for turmeric and curcumin alone. This split is made from product names and can misfile some products. Most-reported products: Puritan'S Pride Turmeric Curcumin (20); Turmeric (12); Puritan'S Pride Turmeric (9); Youtheory Turmeric (6); Puritan'S Pride Turmeric Curcumin 500Mg Rapid Release Capsules (6); Puritans Pride Turmeric 400 Mg Rapid Release Capsules (5).
| Most reported reactions (single-ingredient products) | Reports |
|---|---|
| Nausea | 29 |
| Dizziness | 22 |
| Fatigue | 21 |
| Dyspnoea | 17 |
| Diarrhoea | 16 |
| Jaundice | 16 |
| Pain | 16 |
| Vomiting | 16 |
| Asthenia | 14 |
| Hospitalisation | 13 |
| Pruritus | 12 |
| Hepatic enzyme increased | 11 |
Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (139), Hospitalization (93), Visited Emergency Room (62), Visited a Health Care Provider (59), Other Serious Outcome (34), Life Threatening (25), Disability (11), Other Outcome (10).
Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.
Registered trials
147 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.
- Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy Completed Results posted
- Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer Completed Results posted
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia Completed Results posted
- Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Completed Results posted
- Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease Completed Results posted
- Resveratrol and Vascular Function in CKD Completed Results posted
- Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease Completed Results posted
- High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis. Completed Results posted
- Resveratrol for Pain Due to Endometriosis Completed Results posted
- Effects of Botanical Microglia Modulators in Gulf War Illness Completed Results posted
- Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma Completed Results posted
- Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a Completed Results posted
- Trial of Curcumin in Advanced Pancreatic Cancer Completed Results posted
- Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD Completed Results posted
- A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) Completed Results posted
- Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia Completed Results posted
- Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease Completed Results posted
- Estrogen and Diabetes Completed Results posted
- Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans Completed Results posted
- Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Active, not recruiting Results posted